ClinicalMetric / Countries / Czech Republic
← All Countries
🇨🇿
COUNTRY FEED

Clinical Trials in Czech Republic

Active recruiting clinical trials with sites in Czech Republic. Select a condition below to see detailed trial listings.

Total Trials: 61 // Recruiting: 61 // Updated: Daily

Czech Republic currently has 61 clinical trials with at least one registered site in the country, of which 61 are actively recruiting participants. The most studied conditions at Czech Republic sites are Atrial Fibrillation, Obesity, Parkinson Disease, reflecting where local investigators and sponsors are concentrating enrolment.

Studies are led by sponsors including Charles University, Czech Republic, University Hospital Ostrava, Pfizer. By stage, active Czech Republic trials break down as Phase 1 (4), Phase 2 (12), Phase 3 (13), Phase 4 (3). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.

Top Conditions in Czech Republic

Atrial Fibrillation 3 Obesity 2 Parkinson Disease 2 Intensive Care Unit-acquired Weakness 1 Lactating Women - Human Milk Donors 1 Lewy Body Dementia Psychosis 1 Prolonged Mechanical Ventilation 1 Critical Illness 1 Intravenous Cannulation 1 ACUTE LYMPHOBLASTIC LEUKEMIA 1 Respiratory Infection 1 Invasive Pulmonary Aspergillosis 1 Predictive Cancer Model 1 Peri-implantitis 1 Periodontitis 1 Non-surgical Periodontal Therapy 1 Non Hodgkin Lymphoma (NHL) 1 Temporomandibular Joint Dysfunction; Myofascial Pain Syndrome; Orofacial Pain; Musculoskeletal Disorders 1 MASH 1 MASLD 1
All Countries → All Trials →

Other Countries in This Region

🇬🇷Greece 🇩🇪Germany 🇫🇷France 🇮🇹Italy 🇪🇸Spain 🇬🇧United Kingdom 🇳🇱Netherlands 🇧🇪Belgium 🇵🇱Poland 🇸🇪Sweden
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology